Bacteriocins: Exploring alternatives to antibiotics in mastitis treatment

Brazilian Journal of Microbiology

Volumn 41, Issue 3, 2010, Pages 542-562

  Pieterse, Reneé ^a   Todorov, Svetoslav D ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibiotic; Bacteriocin; Food safety; Mastitis; Milk

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); BOS;

EID: 77954295718     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822010000300003     Document Type: Review

References (104)

1. Allgaier, H.; Jung, G.; Werner, R.G.; Schneider, U.; Zahner, H. (1986). Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur. J. Biochem., 160: 9-22.
2. Almeida, R.A.; Batcha, T.; Oliver, S.P. (2005). Persistence of Streptococcus uberis in bovine mammary epithelial cells. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 137- 142.
3. Almeida, R.A.; Oliver, S.P. (1995). Invasion of bovine mammary epithelial cells by Streptococcus dysgalactiae. J. Dairy Sci., 78: 1310- 1317.
4. Berry, E.A.; Hillerton, J.E. (2002). The Effect of an Intramammary Teat Seal on New Intramammary Infections. J. Dairy Sci., 85: 2512-2520.
5. Bhatti, M.; Veeramachaneni, A.; Shelef, L.A. (2004). Factors affecting the antilisterial effects of nisin in milk. Int. J. Food. Microbiol., 97: 215-219.
6. Blood, D.C.; Studdert, V.P. (1999). Saunders Comprehensive Veterinary Dictionary. 2nd Ed, WB Saunders, London, United Kingdom.
7. Bower, C.K.; Parker, J.E.; Higgins, A.Z.; Oest, M.E.; Wilson, J.T.; Valentine, B.A.; Bothwell, M.K.; McGuire, J. (2002). Protein antimicrobial barriers to bacterial adhesion: in vitro and in vivo evaluation of nisin-treated implantable materials. Coll. Surf.: B: Biointerfer., 25: 81-90.
8. Bradley, A.J. (2002). Bovine Mastitis: An Evolving Disease. Vet. J., 164: 116-128.
9. Bradley, A.J.; Green, M.J. (2001). Aetiology of clinical mastitis in six Somerset dairy herds. Vet. Rec., 148: 683-686.
10. Bradley, A.; Newton, H.; Benchaoui, H.; Tilt, N.; Cracknell, V.; Rowan, T. (2005). Orbeseal® and Orbenin® for the treatment of intra-mammary infections at drying off and prevention of new infections during the dry period and early lactation in dairy cows. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 339-344.
11. Braun, V.; Pilsl, H.; Gross, P. (1994). Colicins: structures, modes of action, transfer through membranes, and evolution. Arch. Microbiol., 161: 199-206.
12. Briko, N.I.; Zhuravlev, M.V. (2004). Use of tomicid in prophylaxis of respiratory streptococcal infection in the organised groups of children of pre-school age. Zh. Mikrobiol. Epidemiol. Immunobiol., 4: 17-20.
13. Calvino, L.F.; Oliver, S.P. (1998). Invasion and Persistence of Streptococcus dysgalactiae Within Bovine Mammary Epithelial Cells. J. Dairy Sci., 81: 678-686.
14. Cintas, L.M.; Casaus, P.; Fernandez, M.F.; Hernandes, P.E. (1998). Comparative antimicrobial activity of enterocin L50, pediocin, PA-1, nisin A and lactocin S against spoilage and food borne pathogenic bacteria. Food Microbiol., 15: 289-298.
15. Cotter, P.D.; Hill, C.; Ross, R.P. (2005). Bacteriocins: Developing innate immunity for food. Nature Rev. Microbiol., 3: 777-788.
16. Crispie, F.; Twomey, D.; Flynn, J.; Hill, C.; Ross, P.; Meaney, W. (2005). The lantibiotic lacticin 3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus. J. Dairy Res., 72: 159-167.
17. Crist, W.L.; Harmon, R.J.; O'Leary, J.; McAllister, A.J. (1997). Mastitis and Its Control. [online]. Available from: http://www.ca.uky.edu/agc/pubs/asc/asc140/asc140.pdf. [Accessed11 June 2007].
18. Cutter, C.N.; Siragusa, G.R. (1995). Population reductions of Gram negative pathogens following treatments with nisin and chelators under various conditions. J. Food Prot., 58: 977-983.
19. Delves-Broughton, J. (1990). Nisin and its use as a food preservative. Food Technol., 44: 100-117.
20. De Vliegher, S.; Laevens, H.; Devriese, L.A.; Opsomer, G.; Leroy, J.L.M.; Barkrama, H.W.; de Kruif, A. (2003). Prepartum teat apex colonization with Staphylococcus chromogenes in dairy heifers is associated with low somatic cell count in early lactation. Vet. Microbiol., 92: 245-252.
21. Dogan, B.; Klassig, S.; Simpson, K.; Oliver, S.; Almeida, R.; Schukken, Y.H. (2005). Pathogenesis of chronic intramammary Escherichia coli infections. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp.131-136.
22. Dopfer, D.; Almeida, R.A.; Lam, T.J.G.M.; Nederbragt, S.P.; Oliver, S.P.; Gasstra, W. (2000). Adhesion and invasion of Escherichia coli from recurrent clinical cases of bovine mastitis. Vet. Microbiol., 74: 331-343.
23. Dos Santos Nascimento, J.S.; Fagundes, P.C.; Brito, M.A.V.P.; Santos, K.R.N.; Bastos, M.C.F. (2005). Production of bacteriocins involved in bovine mastitis. Vet. Microbiol., 106: 61-71.
24. Du Preez, J.H. (2000). Bovine mastitis therapy and why it fails. J. South Afr. Vet. Assoc., 71: 201-208.
25. Ekman, T.; Østerås, O. (2003). Mastitis Control and Dry Cow Therapy in the Nordic Countries [online]. Available from: http://nmconline.org/articles/nordic.pdf. [Accessed 30 March 2009].
26. Flint, S.H.; Ward, L.J.H.; Brooks, D. (1999). Streptococcus waius sp. nov., a thermophylic streptococcus from a biofilm. Int. J. Syst. Bacteriol., 49: 759-767.
27. Fredericq, P.; Levine, M. (1947). Antibiotic relationships and the enteric group of bacteriocin. J. Bacteriol., 54: 785-792.
28. Georgalaki, M.D.; van den Berghe, E.; Kritikos, D.; Devreese, B.; van Beeuman, J.; Kalantzopoulos, G.; de Vuyst, L.; Tsakalidou, E. (2002). Macedocin, a food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Appl. Environ. Microbiol., 68: 5891-5903.
29. Giesecke, W.H.; Du Preez, J.H.; Petzer, I.-M. (1994). Practical Mastitis Control in Dairy Herds. Butterworth Publishers: Durban, South Africa.
30. Gillor, O.; Nigro, L.M.; Riley, M.A. (2005). Genetically Engineered Bacteriocins and their Potential as the Next Generation of Antimicrobials. Curr. Pharm. Des., 11: 1067-1075.
31. Goldstein, B.P.; Wei, J.; Greenberg, K.; Novick, R. (1998). Activity of nisin against Streptococcus pneumonia, in vitro, and in mouse infection model. J. Antimic. Chemother., 42: 277-278.
32. Golshmid, V.K.; Landsman, N.M. (1989). The properties of the antibacterial preparation tomicid and the prospects of its use fro treating staphylodermas. Vestnik Dermatol Venerol, 6: 62-64.
33. Gratia, A. (1925). Sur un remarquable exemple d'antagonisme entre deux souches de colibacille. C. R. Seances Soc. Biol. Fil. 93: 1040-1041.
34. Gruet, P.; Maincent, P.; Merthelot, X.; Kaltsatos, V. (2001). Bovine mastitis and intramammary drug delivery: review and perspectives. Adv. Drug Deliv. Rev, 50: 245-259.
35. Hancock, R.E.W. (1997). Peptide antibiotics. Lancet, 349: 418-420.
36. Haveri, M.; Roslöf, A.; Rantala, L.; Pyörälä, S. (2005). Toxin genes of Staphylococcus aureus isolated from bovine intramammary infection of different clinical characteristics and outcome. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 149-154.
37. Heng, C.K.; Swe, P.W.; Ting, Y.-T.; Dufour, M.; Baird, H.; Ragland, N.L.; Burtenshaw, G.A.; Jack, R.W.; Tagg, J.R. (2006). The large antimicrobial proteins (bacteriocins) of streptococci. Int. Congress Ser., 1289: 351-354.
38. Hillman, J.D. (2001). Replacement therapy of dental caries. Operat. Dent., Supplement 6: 39-40.
39. Immucell Corporation. [online]. Available from: http//www.immucell.com/pf/whats_new.php. [Accessed: 11 December 2008].
40. Ivanova, I.; Miteva, V.; Stefanova, T.; Pantev, A.; Budakov, I.; Danova, S.; Moncheva, P.; Nikolova, I.; Dousset, X.; Boyaval, P. (1998). Characterisation of a bacteriocin produced by Streptococcus thermophilus 81. Int. J. Food Microbiol., 42: 147-158.
41. Jack, R.W.; Tagg, J.R.; Ray, B. (1995). Bacteriocins of gram-positive bacteria. Microbiol. Rev., 59: 171-200.
42. Jacob, F.A.; Lwoff, A.; Siminovitch, A.; Wollman, E. (1953). Définition de quelques termes relatifs à la lysogénie. Ann. Instit. Pasteur (Paris), 84: 222-224.
43. Jordi, B.J.; Boutaga, K.; van Heeswijk, C.M.; van Knapen, F.; Lipman, L.J. (2001). Sensitivity of Shiga toxin-producing Escherichia coli (STEC) strains for colicins under different experimental conditions. FEMS Microbiol. Lett., 204: 329-334.
44. Kellner, R.; Jung, G.; Horner, T.; Zahner, H.; Schnel, N.; Entian, K.D.; Gotz, F. (1988). Galldermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem., 177: 53-59.
45. Klaenhammer, T.R. (1993). Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev., 12: 39-86.
46. Lactodata, (2006). Lactodata Statistics. 9: 2-15. [online]. Available from: http://www.dairymail.co.za/acrobat/web_oct_06/LACTO_DATA.pdf. Accessed: 6 March 2007.
47. Lombardi, A.; Gatti, M.; Rizzotti, L.; Torriani, S.; Andrighetto, C.; Giraffa, G. (2004). Characterization of Streptococcus macedonicus strains isolated from artisanal Italian raw milk cheeses. Int. Dairy J., 14: 967-976.
48. Manachini, P.L.; Flint, S.H.; Ward, L.J.H.; Kelly, W.; Fortina, M.G.; Parini, C.; Mora, D. (2002). Comparison between Streptococcus macedonicus and Streptococcus waius strains and reclassification of Streptococcus waius (Flint et al. 1999) as Streptococcus macedonicus (Tsakalidou et al., 1998). Int. J. Syst. Evolut. Microbiol., 52: 945-951.
49. Mantovani, H.C.; Hu, H.; Worobo, R.W.; Russell, J.B. (2002). Bovicin HC5, a bacteriocin from Streptococcus bovis HC5. Microbiol., 148: 3347-3352.
50. Marciset, O.; Jeronimus-Stratingh, M.C.; Mollet, B.; Poolman, B. (1997). Thermophilin 13, a Nontypical Antilisteral Pration Complex Bacteriocin, that functions without a Receptor. J. Biol. Chem., 272: 14277-14284.
51. Mathot, A.G.; Beliard, E.; Thault, D. (2003). Streptococcus thermophilus 580 produces a bacteriocin potentially suitable for inhibition of Clostridium tyrobutyricum in hard cheese. J. Dairy Sci, 86: 3068-3074.
52. Melchior, M.B.; Vaarkamp, H.; Fink-Gremmels, J. (2006). Biofilms: A role in recurrent mastitis infections? Vet. J., 171: 298-407.
53. McAuliffe, O.; Ryan, M.P.; Ross, R.P.; Hill, C.; Breuwer, P.; Abee, T. (1998). Lacticin 3147, a Broad-Spectrum Bacteriocin Which Selectively Dissipates the Membrane Potential. Appl. Environ. Microbiol., 64: 439-445.
54. Miles, H.; Lesser, W.; Sears, P. (1992). The Economic Implications of Bioengineered Mastitis Control. J. Dairy Sci., 75: 596-605.
55. Moreno, F.; San Millan, J.H.; Hernandez-Chico, C.; Kolter, R. (1995). Microcins. Biotechnol., 28: 307-321.
56. Mota-Meira, M.; LaPointe, G.; Lacroix, C.; Lavoie, M.C. (2000). MICs of Mutacin B-Ny266, Nisin A, Vancomycin, and Oxacillin against Bacterial Pathogens. Antimicrob. Agents Chemother., 44: 24-29.
57. Mota-Meira, M.; Morency, H.; Lavoie, M.C. (2005). In vivo activity of mutacin B-Ny266. J. Antimicrob. Chemother., 56: 869-871.
58. Moyo, N.; Nielen, M.; Kruitwagen, C.; Beynen, A.C. (2005). Vitamin E supplementation and udder health: A meta-analysis. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 159-165.
59. NCCLS. (2002). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard. 2nd ed. NCCLS, Wayne, Pennsylvania, USA.
60. NMC. (2006). NMC Factsheet - Dry Cow Therapy [online]. Available from: http://www.nmconline.org/drycow.htm. [Accessed 29 March 2007].
61. Oliver, S.P.; Sordillo, L.M. (1988). Udder health in the peripartrient period. J. Dairy Sci., 71: 2584-2606.
62. Pawar, D.D.; Malik, S.V.S.; Bhilegaonkar, K.N.; Barbuddhe, S.B. (2000). Effect of nisin and its combination with sodium chloride on the survival of Listeria monocytogenes added to raw buffalo meat mince. Meat Sci., 56: 215-219.
63. Petroviski, K.R.; Trajcev, M.; Buneski, G. (2006). A review of the factors affecting the costs of bovine mastitis. J. South Afr. Vet. Ass., 77: 52-60.
64. Pfizer Animal Health. (2004). How to use Orbeseal [online]. Available from: http://www.orbeseal.com/product_overview.asp?drug=ORcountry=US lang=ENspecies=DAsec. [Accessed 28 April 2009].
65. Philpot, W.N.; Nickerson, S.C. (1999). Mastitis: Counter Attack. Westfalia Surge LLC: Illinois, USA.
66. Prescott, L.M.; Harley, J.P.; Klein, D.A. (1996). Microbiology. 3rd ed., Wm. C. Brown Publishers, Dubuque, USA
67. Quinn, P.J.; Carter, M.E.; Markey, B.; Carter, G.R. (1999). Clinical Veterinary Microbiology. Harcourt Publishers Ltd.: London.
68. Reddy, K.V.R.; Aranha, C.; Gupta, S.M.; Yedery, R.D. (2004). Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduct., 128: 117-126.
69. Rhur, E.; Sahl, H.-G. (1985). Mode of action of the peptide antibiotic nisin and influence of the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother., 27: 841-845.
70. Rilla, N.; Martínes-Delgado, T.; Rodríguez, A. (2003). Inhibition of Clostridium tyrobutyricum in Vidiago cheese by Lactococus lactis ssp. lactis IPLA 729, a nisin Z producer. Int. J. Food Microbiol., 85: 23-33.
71. Rogers, L.A. (1928). The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus. J. Bacteriol., 16: 321-325.
72. Russell, J.B.; Mantovani, H.C. (2002). The bacteriocins of ruminal bacteria and their potential as an alternative to antibiotics. J. Mol. Microbiol. Biotechnol., 4: 347-355.
73. Ryan, M.P.; Meaney, W.J.; Ross, R.P.; Hill, C. (1998). Evaluation of Lacticin 3147 and a Teat Seal Containing This Bacteriocin for Inhibition of Mastitis Pathogens. Appl. Environ. Microbiol., 64: 2287-2290.
74. Ryan, M.P.; Rea, M.C.; Hill, C.; Ross, R.P. (1996). An application in Cheddar Cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl. Environ. Microbiol., 62: 612-619.
75. Sable, S.; Pons A.M.; Gendron-Gaillard, S.; Cottenceau, G. (2000). Antibacterial activity evaluation of microcin J25 against diarrheagenic Escherichia coli. Appl. Environ. Microbiol., 66: 4595-4597.
76. Sahl, H.-G. (1991). Pore formation in bacterial membranes by cationic lantibiotics. In; Jung, G., Sahl, H. -G. (Eds.), Nisin and Noval Lantibiotics. ESCOM Science, Leiden, The Netherlands, pp. 347-358.
77. Sandgren, C.H.; Ekman, T. (2005). Animal welfare: Of increasing importance in modern dairy production. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 75-81.
78. Schillinger, U.; Geison, R.; Holzapel, W.H. (1996). Potential of antagonistic microorganisms and bacteriocin for the bacteriological preservation of foods. Trends Food Sci. Technol., 7: 158-164.
79. Schroeder, J.W. (2007). Mastitis Control Programs: Bovine Mastitis and Milking Management [online]. Fargo: North Dakota State University Agriculture and University Extension. Available from: http://www.ag.ndsu.edu/pubs/ansci/dairy/as1129w.htm. [Accessed 25 May 2009].
80. Schukken, Y.H.; Tikofsky, L.L.; Zadoks, R.N. (2005). Environmental control for mastitis prevention, milk quality and food safety. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 109-114.
81. Sears, P.M.; Smith, B.S.; Stewart, W.K.; Gonazalez, R.N. (1992). Evaluation of a Nisin-based Germicidal Formulation on Teat Skin of Live Cows. J. Dairy Sci., 75: 3185-3190.
82. Shryock, T. (2004). The future use of anti-infective products in animal health. Nature Rev. Microbiol., 2: 425-430.
83. Soback, S.; Saran, A. (2005). New antimicrobial agents in mastitis therapy In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 53-57.
84. Sol, J. (1984). Control Methods in Summer Mastitis: The importance of fly control. 1984. In: Proceedings of the XIIIth World Congress on Diseases of Cattle, Durban, 17-21st September 1984, South African Veterinary Association, Pretoria, pp. 236-242.
85. Suszkiw, J. (2006). New Mastitis Treatment May Offer Alternative to Antibiotics. Agric. Res., 20: 14-25.
86. Tagg, J.R. (2004). Prevention of streptococcal pharyngitis by anti- Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Ind. J. Med. Res., 119: 13-16.
87. Tagg, J.R.; Dajani, A.S.; Wannamaker, L.W. (1976). Bacteriocins of gram-positive bacteria. Bacteriol. Rev., 40: 722-756.
88. Tagg, J.; Wescombe, P.; Burton, J. (2006). Oral streptococcal BLIS: Heterogeneity of the effector molecules and potential role in the prevention of streptococcal infections. Int. Congr. Series, 1289: 347-350.
89. Talbot, B.G.; Lacasse, P. (2005). Progress in the development of mastitis vaccines. Livest. Product. Sci., 98: 101-113.
90. Tamilselvam, B.; Almeida, R.A.; Dunlap, J.R.; Oliver, S.P. (2006). Streptococcus uberis internalises and persists in bovine mammary cells. Microb. Pathogen., 40: 279-285.
91. Taylor, J.I.; Hirsh, A.; Mattick, A.T.R. (1949). The treatment of bovine streptococcal and staphylococcal mastitis with nisin. Vet. Res., 61: 197-198.
92. Tsakalidou, E.; Zoidou, E.; Pot, B.; Wassill, L.; Ludwig, W.; Devriese, L.A.; Kalantzopoulos, G.; Schleifer, K.H.; Kersters, K. (1998). Identification of Streptococci from Greek Kasseri cheese and description of Streptococcus macedonicus sp. nov. Int. J. Syst. Bacteriol., 48: 519-527.
93. Twomey, D.P.; Wheelcock, A.I.; Flynn, J.; Meaney, W.J.; Hill, C.; Ross, R.P. (2000). Protection against Staphylococcus aureus Mastitis in Dairy Cows Using a Bismuth-Based Teat Seal Containing the Bacteriocin, Lacticin 3147. J. Dairy Sci., 83: 1981-1988.
94. Van den Berghe, E.; Skourtas, G.; Tsakalidou, E.; De Vuyst, L. (2006). Streptococcus macedonicus ACA-DC 198 produces the lantibiotic macedocin, at temperature and pH conditions that prevails during cheese manufacture. Int. J. Food Microbiol., 107: 138-147.
95. Vangroenweghe, F.; Lamote, I.; Burvenich (2005). Physiology of the periparturient period and its relation to severity of clinical mastitis. Dom. Animal Endocrinol., 29: 283-293.
96. Walls, T.; Power, D.; Tagg, J. (2003). Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect otitis media? J. Med. Microbiol., 52: 529-833.
97. Whitford, M.F.; McPherson, M.A.; Forster, R.J.; Teather, R.M. (2001). Identification of Bacteriocin-like Inhibitors from Rumen Streptococcus spp. and Isolation and Characterization of Bovicin 255. Appl. Environ. Microbiol., 67: 569-574.
98. Wiedemann, I.; Böttiger, T.; Bonelli, R.R.; Wiese, A.; Hagge, S.O.; Gutsmann, T.; Seydel, U.; Deegan, L.; Hill, C.; Ross, P.; Sahl, H.-G. (2006). The mode of action of the lantibiotic lacticin 3147 - a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol., 61: 285-296.
99. Wirawan, R.E.; Jack, R.W.; Tagg, J.R. (2006). A novel combination of bacteriocins produced by Streptococcus uberis strain 42. Int. Congr. Ser., 1289: 355-358.
100. Wirawan, R.E.; Kleese, N.A.; Jack, R.W.; Tagg, J.R. (2006). Molecular and Genetic Characterisation of a Novel Nisin Variant Produced by Streptococcus uberis. Appl. Environ. Microbiol., 72: 1148-1156.
101. Woodward, W.D.; Besser, T.E.; Ward, A.C.S.; Corbeil, L.B. (1987). In vitro Growth Inhibition of Mastitis Pathogens by Bovine Teat Skin Normal Flora. Can. J. Vet. Res., 51: 27-31.
102. Wooley, R.E.; Gibbs, P.S.; Schott, E.B. (1999). Inhibition of Salmonella typhimurium in chicken intestinal tract by transformed avirulent avian Escherichia coli. Avian Disease 43: 245-250.
103. Zecconi, A. (2005). Pathogenesis of mastitis and mammary gland immunity: Where we are and where we should go. In: Hogeveen, H. (ed.), Mastitis in dairy production Current knowledge and future solutions, Wageningen Academic Publishers, The Netherlands, pp. 31- 40.
104. Ziv, G. (1980). Drug selection and use in mastitis: systemic versus local drug therapy. J. Amer. Vet. Med. Ass., 176: 1109-1115.